Comorbidities in rheumatoid arthritis

被引:318
作者
Michaud, Kaleb
Wolfe, Frederick
机构
[1] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA
[2] Natl Data Bank Rheumat Dis, Wichita, KS USA
[3] Univ Kansas, Sch Med, Wichita, KS 67214 USA
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2007年 / 21卷 / 05期
关键词
anti-TNF therapy; cardiovascular disease; comorbid condition; comorbidity index; comorbidity; infection; malignancy; outcomes; rheumatoid arthritis;
D O I
10.1016/j.berh.2007.06.002
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Rheumatoid arthritis (RA) is often characterized by the burden of swollen joints, pain, and decreased physical function, but less understood are the many manifestations of additional health conditions that are associated with RA and its treatments. First brought to light with observations of increased mortality in RA, studies noted the increased rates of cardiovascular and infection events. The chronic, debilitating, autoimmune nature of IRA affects the patient directly or indirectly in almost all organ systems, from cardiovascular problems and infections to depression and gastrointestinal ulcers. On average, the established RA patient has two or more comorbid conditions. It should be the responsibility of the rheumatologist to take these and the risk of additional conditions into account when treating the patient. This chapter reviews important comorbidities in patients with RA, their prevalence, and their relation to RA.
引用
收藏
页码:885 / 906
页数:22
相关论文
共 174 条
[1]
Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis - A multicenter, case-control study [J].
Alarcon, GS ;
Kremer, JM ;
Macaluso, M ;
Weinblatt, ME ;
Cannon, GW ;
Palmer, WR ;
StClair, EW ;
Sundy, JS ;
Alexander, RW ;
Smith, GJW ;
Axiotis, CA .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (05) :356-+
[3]
Ang DC, 2005, J RHEUMATOL, V32, P1013
[4]
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH [J].
Anker, SD ;
Coats, AJS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (2-3) :123-130
[5]
Assessing utility values in rheumatoid arthritis:: A comparison between time trade-off and the EuroQol [J].
Ariza-Ariza, Rafael ;
Hernandez-Cruz, Blanca ;
Carmona, Loreto ;
Ruiz-Montesinos, Maria Dolores ;
Ballina, Javier ;
Navarro-Sarabia, Federico .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (05) :751-756
[6]
ARKINS SR, 2006, ANN RHEUM DIS, V65, P677
[7]
Cancer and interstitial lung disease [J].
Artinian, V ;
Kvale, PA .
CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (05) :425-434
[8]
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden [J].
Askling, J ;
Fored, CM ;
Brandt, L ;
Baecklund, E ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Romanus, V ;
Klareskog, L ;
Feltelius, N .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :1986-1992
[9]
Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Baecklund, E ;
Brandt, L ;
Backlin, C ;
Ekbom, A ;
Sundström, C ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L ;
Feltelius, N .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1414-1420
[10]
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Brandt, L ;
Baecklund, E ;
Bertilsson, L ;
Feltelus, N ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1421-1426